TransMedics Group Inc.

NASDAQ: TMDX · Real-Time Price · USD
127.38
-2.36 (-1.82%)
At close: Aug 15, 2025, 3:44 PM

TransMedics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
157.37M 143.54M 121.62M 108.76M 114.31M 96.85M 81.17M 66.43M 52.47M 41.55M 31.38M 25.68M 20.52M 15.88M 9.67M 5.37M 8.17M 7.05M
Cost of Revenue
60.78M 55.31M 49.61M 47.92M 45.14M 36.99M 33.25M 25.77M 15.72M 12.79M 10.67M 7.57M 6.17M 3.78M 2.68M 1.6M 2.58M 2.24M
Gross Profit
96.59M 88.23M 72.01M 60.84M 69.16M 59.86M 47.92M 40.66M 36.74M 28.77M 20.7M 18.11M 14.35M 12.1M 6.99M 3.77M 5.59M 4.81M
Operating Income
36.57M 27.44M 8.64M 3.92M 12.51M 12.42M 2.6M -28.34M -906K -2.09M -6.78M -5.54M -9.74M -9.37M -11.33M -11.72M -9.87M -6.51M
Interest Income
2.5M n/a 2.92M 3.3M 3.4M 3.57M 4.76M 5.2M 2.43M 555K 1.08M 400K n/a n/a n/a n/a 171K n/a
Pretax Income
36.18M 26.68M 6.99M 4.25M 12.15M 12.39M 3.86M -26.93M -980K -2.63M -6.7M -7.41M -11.5M -10.56M -12.65M -12.95M -10.66M -7.91M
Net Income
34.91M 25.68M 6.86M 4.22M 12.19M 12.2M 4.03M -25.42M -1M -2.64M -6.72M -7.43M -11.52M -10.56M -12.67M -12.96M -10.67M -7.92M
Selling & General & Admin
44.09M 43.63M 46.91M 42.66M 42.8M 36.06M 34.56M 30.65M 29.36M 24.98M 21.73M 16.85M 17.38M 13.94M 12M 10.34M 9.16M 6.79M
Research & Development
15.93M 17.16M 16.46M 14.27M 13.86M 11.38M 10.76M 38.34M 8.29M 5.87M 5.76M 6.81M 6.71M 7.53M 6.31M 5.16M 6.29M 4.53M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
60.02M 60.78M 63.37M 56.92M 56.65M 47.44M 45.32M 69M 37.65M 30.86M 27.48M 23.66M 24.09M 21.47M 18.31M 15.5M 15.46M 11.32M
Interest Expense
3.48M 3.46M 3.57M 3.62M 3.62M 3.6M 3.6M 3.59M 2.5M 1.09M 1.01M 787K 872K 960K 978K 979K 965K 952K
Selling & Marketing Expenses
n/a n/a n/a n/a -100K -100K n/a n/a 1.42M n/a 18.21M n/a 1.19M n/a n/a n/a n/a n/a
Cost & Expenses
120.8M 116.09M 112.98M 104.84M 101.8M 84.43M 78.57M 94.77M 53.37M 43.64M 38.15M 31.23M 30.27M 25.25M 21M 17.09M 18.04M 13.56M
Income Tax Expense
1.27M 994K 132K 29K -41K 196K -168K -1.51M 21K 11K 19K 19K 22K 6K 17K 9K 6K 4K
Shares Outstanding (Basic)
33.91M 33.72M 33.59M 33.44M 33.12M 32.76M 32.64M 32.61M 32.55M 32.26M 32.01M 30.23M 27.98M 27.79M 27.77M 27.7M 27.62M 27.37M
Shares Outstanding (Diluted)
40.56M 39.91M 35.21M 35.68M 35.29M 34.68M 34.18M 32.61M 32.55M 32.26M 32.01M 30.23M 27.98M 27.95M 27.77M 27.7M 27.62M 27.37M
EPS (Basic)
1.03 0.76 0.20 0.13 0.37 0.37 0.12 -0.78 -0.03 -0.08 -0.21 -0.25 -0.41 -0.38 -0.46 -0.47 -0.39 -0.29
EPS (Diluted)
0.92 0.70 0.19 0.12 0.35 0.35 0.12 -0.78 -0.03 -0.08 -0.21 -0.25 -0.41 -0.38 -0.46 -0.47 -0.39 -0.29
EBITDA
46.39M 36.27M 16.24M 13.04M 17.11M 16.82M 11.17M -21.45M 3.15M -56K -4.22M -5.55M -9.74M -8.91M -10.38M -11.52M -9.25M -6.52M
EBIT
39.66M 30.14M 10.56M 3.92M 12.51M 12.42M 7.47M -23.34M 1.52M -1.53M -5.69M -6.62M -10.53M -9.6M -11.67M -11.97M -9.7M -6.96M
Depreciation & Amortization
6.73M 6.14M 5.68M 9.12M 4.6M 4.4M 3.71M 1.89M 1.62M 1.48M 1.47M 1.07M 969K 685K 1.29M 455K 451K 445K